Statistics for Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
Total visits
| views | |
|---|---|
| Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer | 2 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| 41467_2023_Article_37727.pdf | 7 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Greenwood | 2 |